Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 13138Triple Negative Breast Neoplasms 1150Neoplasms 750Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 581Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 536Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 204Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Behavioral Symptoms × Breast × Clear all
NCT04379414 2025-12-09

YES

Dana-Farber Cancer Institute

Phase NA Active not recruiting
400 enrolled
Breast

Behavioral Symptoms, Breast Neoplasms

NCT02043184 2017-06-07

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Michigan State University

Phase NA Completed
322 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Behavioral Symptoms, Breast Neoplasms, Depression, Leukemia, Melanoma, Neoplasms, Patient Acceptance of Health Care, Prostatic Neoplasms, Colorectal Neoplasms, Neurobehavioral Manifestations, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡